Modified prosthetic vascular conduits.

Authors:Muneera R Kapadia, Daniel A Popowich, Melina R Kibbe
Language:Eng.
Date:08-04-2008
Journal:Circulation (1524-4539)
Release:Circulation. 2008 Apr;117(14):1873-82


Abstract:



Atherosclerosis in the form of peripheral arterial disease results in significant morbidity. Surgical treatment options for peripheral arterial disease include angioplasty, endarterectomy, and bypass grafting. For bypass grafting, vein remains the conduit of choice; however, poor quality and limited availability have led to the use of prosthetic materials. Unfortunately, because of a lack of endothelium and compliance mismatch, neointimal hyperplasia develops aggressively, resulting in high failure rates. To improve graft patency, investigators have developed surgical, chemical, and biological graft modifications. This review describes common prosthetic materials, as well as approaches currently in use and under investigation to modify and improve prosthetic conduits for bypass grafting in an effort to improve graft patency rates.

Copyright:Circulation

Northwestern University Feinberg School of Medicine, Division of Vascular Surgery, Chicago, IL 60611, USA.
Full text:
HighWire Press - HTML (needs subscription)
Ovid Technologies, Inc. - HTML (needs subscription)
Swets Information Services - HTML (needs subscription)
Terms:Animals, Anticoagulants, Biocompatible Materials, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation, Clinical Trials as Topic, Coated Materials, Biocompatible, Drug Implants, Endothelial Cells, Equipment Design, Equipment Failure, Graft Occlusion, Vascular, Humans, Nitric Oxide Donors, Polytetrafluoroethylene, Polyurethanes, Postoperative Complications, Retrospective Studies, Transplantation, Autologous
 
Add to my archiveAdd to my archive


Send to a friendSend to a friend
Circulation